Keyphrases
SCell
50%
Activation Complex
50%
Notch Activation
50%
Human Peripheral Blood Lymphocytes
50%
Cyclin D3
50%
Bromfenac
50%
S-phase Kinase-associated Protein 2 (Skp2)
50%
Cyclin-dependent Kinase 9 (CDK9)
50%
Ion Elution
50%
MRL Mouse
50%
Epimorphic Regeneration
50%
Mouse Ear
50%
Elution Rate
50%
Accelerated Senescence
50%
Oxide Coatings
50%
Silver Nitrate
50%
S&P 100
50%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
25%
Post-LASIK
25%
Platform Strategy
25%
Commercial Specification
25%
Histological Difference
25%
Memory Strategies
25%
Postcataract
25%
Peak Concentration
25%
Ophthalmic Solutions
25%
Corneal Abrasion
25%
Commercial Property
25%
Ag +
20%
Backcross
16%
Hydra
16%
Cycle Type
16%
Axolotl
16%
GADD45A
16%
Knock-in mutation
16%
Appendage Regeneration
16%
Ear pinna
16%
Via Hole
16%
Hair Follicle
16%
Healing Capacity
16%
Blastema
16%
Nuclear Domain 10 (ND10)
16%
Cyclin T1
12%
Target Suppression
12%
Notch Effect
12%
Notch Pathway
12%
Notch Targets
11%
PML Bodies
11%
MYC Expression
10%
Solid Media
10%
Immunology and Microbiology
Notch
100%
Steady State
50%
T Cell
50%
Elution
50%
Cell Cycle
50%
Cyclin T1
50%
Elongation Factor
25%
Oncogene C Myc
10%
Notch Signaling
8%
Gene Expression
7%
Downregulation
7%
Lineages
7%
Enzyme Active Site
7%
Human Cell
7%
Transcription Elongation Factor
7%
Bacterial Strain
7%
Bacterial Growth
7%
Proteasome
7%
Salamandridae
5%
Blastema
5%
Hair Follicle
5%
Ambystoma
5%
Oncogene
5%
Cell Cycle Progression
5%
P53
5%
